BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 2 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 13.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $456,783 | -59.9% | 71,150 | -64.9% | 0.00% | – |
| Q3 2022 | $1,139,000 | -32.9% | 202,600 | -31.1% | 0.00% | – |
| Q2 2022 | $1,698,000 | -74.0% | 294,200 | -54.4% | 0.00% | -100.0% |
| Q1 2022 | $6,538,000 | -5.4% | 644,800 | -22.7% | 0.00% | -50.0% |
| Q4 2021 | $6,909,000 | – | 834,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmond Asset Management, LLC | 136,593 | $1,106,000 | 0.35% |
| Total Clarity Wealth Management, Inc. | 11,425 | $93,000 | 0.04% |
| Virtu Financial LLC | 32,952 | $267,000 | 0.02% |
| Apollon Wealth Management, LLC | 19,400 | $157,000 | 0.02% |
| Summit Trail Advisors, LLC | 35,000 | $284,000 | 0.02% |
| FNY Investment Advisers, LLC | 4,687 | $37,000 | 0.02% |
| Freedom Investment Management, Inc. | 16,649 | $135,000 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 156,946 | $1,271,000 | 0.01% |
| Belvedere Trading LLC | 13,608 | $107,000 | 0.00% |
| GOFEN & GLOSSBERG LLC /IL/ | 10,000 | $81,000 | 0.00% |